The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 26, 2019
Filed:
Sep. 22, 2016
Applicant:
Synergy Pharmaceuticals, Inc., New York, NY (US);
Inventor:
Kunwar Shailubhai, Audubon, PA (US);
Assignee:
SYNERGY PHARMACEUTICALS, INC., New York, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/10 (2006.01); A61K 45/06 (2006.01); C07K 7/08 (2006.01); C07K 14/00 (2006.01); A61K 38/04 (2006.01); A61K 31/196 (2006.01); A61K 31/4402 (2006.01); A61K 47/55 (2017.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 31/196 (2013.01); A61K 31/4402 (2013.01); A61K 38/04 (2013.01); A61K 45/06 (2013.01); A61K 47/55 (2017.08); A61K 47/64 (2017.08); C07K 7/08 (2013.01); C07K 14/00 (2013.01);
Abstract
This invention provides novel peptides and methods to prevent, control, and treat an inflammation, cancer and other disorders, particularly of the gastrointestinal tract and the lung by administering at least one agonist of guanalyte cyclase receptor either alone or in combination with a compound selected from i) 5-aminosalicyclic acid (5-ASA) or a derivative or a pharmaceutically acceptable salt thereof; ii) mercaptopurine; or iii) an anti-TNF therapy.